ANDA 218642, held by Pharmazone. Topiramate.
As of Nov 15, 2026, ANDA 218642 (Topiramate), held by Pharmazone, was first approved by FDA on Oct 10, 2024, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 10, 2024 | Original application | Approved | None posted |
| Topiramate15MG · capsule;oral | Topiramate | Rx |
| Topiramate25MG · capsule;oral | Topiramate | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters